AstraZeneca succeeded in thwarting Pfizer's takeover plans – but was forced to promise investors that it could deliver very rapid growth – forecasting revenues of $45 billion by 2023, compared ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge, said to be the biggest science lab of its kind in the UK.

Cambridge-headquartered AstraZeneca is investing $2.5 billion in Beijing to establish its sixth global strategic R & D centre ...

"The IT, AstraZeneca ... Beyond the opportunity represented by its colleges and office blocks, though, there is also deprivation. Cambridge is considered one of the most unequal cities in the ...